Donald J. AbrahamCourtney C. Aldrich, Robert S. Wallis, Rory P. Remmel, Pooja Hegde & Christina L. Stallings. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
110
.
Ricardo Figueiredo, Daniela F. Ramos, Cristina Moiteiro, Maria Augusta Medeiros, Maria João Marcelo Curto, José Cardoso de Menezes, Rogelio Hernandez Pando, Pedro E.A. Silva & Maria do Céu Costa. (2012) Pharmacophore insights into rpoB gene mutations in Mycobacterium tuberculosis rifampicin resistant isolates. European Journal of Medicinal Chemistry 47, pages 186-193.
Crossref
Paul A. Aristoff, George A. Garcia, Paul D. Kirchhoff & H.D. Hollis Showalter. (2010) Rifamycins – Obstacles and opportunities. Tuberculosis 90:2, pages 94-118.
Crossref
Ricardo Figueiredo, Cristina Moiteiro, M. Augusta Medeiros, P. Almeida da Silva, D. Ramos, F. Spies, M.O. Ribeiro, M. Cristina S. Louren?o, I.N. J?nior, M. Manuela Gaspar, M. Eug?nia M. Cruz, M. Jo?o Marcelo Curto, S.G. Franzblau, H. Orozco, D. Aguilar, R. Hernandez-Pando & M. C?u Costa. (2009) Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H37Rv, MDR and NRP Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry 17:2, pages 503-511.
Crossref
Eduardo Rubio, Isabel Merino, Ana‐Belén García, María‐Paz Cabal, Cristina Ribas & Miguel Bayod‐Jasanada. (2005) NMR spectroscopic analysis of new spiro‐piperidylrifamycins. Magnetic Resonance in Chemistry 43:4, pages 269-282.
Crossref
Vincent Launay-Vacher, Hassane Izzedine & Gilbert Deray. (2005) Pharmacokinetic Considerations in the Treatment of Tuberculosis in Patients with Renal Failure. Clinical Pharmacokinetics 44:3, pages 221-235.
Crossref
Walter K. Kraft, Jacqueline B. McCrea, Gregory A. Winchell, Alexandra Carides, Richard Lowry, Eric J. Woolf, Sandra E. Kusma, Paul J. Deutsch, Howard E. Greenberg & Scott A. Waldman. (2004) Indinavir and Rifabutin Drug Interactions in Healthy Volunteers. The Journal of Clinical Pharmacology 44:3, pages 305-313.
Crossref
L Santos, M.A Medeiros, S Santos, M.C Costa, R Tavares & M.J.M Curto. (2001) NMR studies of some rifamycins. Journal of Molecular Structure 563-564, pages 61-78.
Crossref
William J. Burman, Keith Gallicano & Charles Peloquin. (2001) Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials. Clinical Pharmacokinetics 40:5, pages 327-341.
Crossref
L. Santos, F. Fant, M. A. Medeiros, F. A. M. Borremans, M. C. Costa & M. J. M. Curto. (2000) Structural characterization by NMR of rifabutinol, a derivative of rifabutin. Magnetic Resonance in Chemistry 38:11, pages 937-945.
Crossref
M. BREDA, M.STROLIN BENEDETTI, M. BANI, C. PELLIZZONI, I. POGGESI, G. BRIANCESCHI, M. ROCCHETTI, L. DOLFI, D. SASSELLA & R. RIMOLDI. (1999) EFFECT OF RIFABUTIN ON ETHAMBUTOL PHARMACOKINETICS IN HEALTHY VOLUNTEERS. Pharmacological Research 40:4, pages 351-356.
Crossref
Allen Cato, John Cavanaugh, Harry Shi, Ann Hsu, John Leonard & Richard Granneman. (1998) The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin*. Clinical Pharmacology & Therapeutics 63:4, pages 414-421.
Crossref
Richard Hafner, James Bethel, Maureen Power, Bernard LandryMary Banach, Larry MoleHarold C. StandifordStephen FollansbeePrincy KumarRalph RaaschDavid CohnDavid Mushatt & George Drusano. (1998) Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers. Antimicrobial Agents and Chemotherapy 42:3, pages 631-639.
Crossref
Eugenia Iatsimirskaia, Samir Tulebaev, Elena Storozhuk, Ilya Utkin, Douglas Smith, Nicholas Gerber & Tatiana Koudriakova. (1997) Metabolism of rifabutin in human enterocyte and liver microsomes: Kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents*. Clinical Pharmacology & Therapeutics 61:5, pages 554-562.
Crossref
Helga Bartels & Rainer Bartels. (1996) Determination of rifabutin by high-performance liquid chromatography using on-line concentration and column switching. Journal of Chromatography B: Biomedical Sciences and Applications 686:2, pages 235-240.
Crossref
M Strolin BenedettiP Dostert. (1994) Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.. Environmental Health Perspectives 102:suppl 9, pages 101-105.
Crossref
I. A. Blair. 1994. Pharmacokinetics of Drugs. Pharmacokinetics of Drugs
41
84
.
Margitta Albinus, Gudrun Amschler, Uwe Amschler, Erwin von Angerer, Wolfgang Barthel, Andrea Bauer, Kurt Bauer, Jürgen Beckmann, Winfried Beil, Jürgen Beitz, Petra Berscht, Thorsten Beyrich, Katja Binder, Roswitha Böhme, Hans-Hubertus Borchert, Franz Bracher, Helmut Bräunlich, Kerstin Brinkmann, Franz von Bruchhausen, Kay Brune, Axel Büge, Wolfram Christ, Monika Cimbollek, Rolf Daniels, Gerd Dannhardt, Hans-Jürgen Duchstein, Siegfried Ebel, Kurt Eger, Peter Emig, Thomas Erker, Maria S. Fernandez-Alfonso, August Wilhelm Frahm, Margarete Frahm, Klaus-Jürgen Freundt, Detlef Geffken, Ulrich Geis, Erika Glusa, Berthold Göber, Jochen Gödicke, Margarete Goppelt-Strübe, Wilhelm Gössling, Annette Graul, Sibylle Greiner, Adolf Grisk, Michael Grosam, Markus von Gruchalla, Michael Gütschow, Axel Haberkorn, Eberhard Hackenthal, Annette Häfner, Boris Haluszczynski, Achim Harder, Sabine Hartmann, Susanne Hartmann, Dieter Heber, Gerhard Heinemeyer, Andreas Hensel, Sibylle Hoedt-Schmidt, Hermann Hoffmann, Ute Hoffmann-Schollmayer, Ulrike Holzgrabe, Martin Hug, Wolfgang Ibrom, Elisabeth Inkmann, Jens Jürgens, Brigitte Kaiser, Dieter-Abbo Kalbhen, Nasser Khudeir, Werner Kiefer, Doris Kleinsorge, Christoph Klett, Stephanie Klett, Martin Klingmüller, H.-P. Klöcking, Gerd Kobal, Axel Kramer, Mareta Kreher, Gottfried Kreutz, Reinhard Kroker, Dorothea Landsiedel-Maier, Jochen Lehmann, Marion Sylvia Lehner, Stefan Leiner, Hans Löwe, Johannes Mann, Detlef Manns, Wolfgang Matthiessen, Andreas Maurer, Wolfgang Meindl, Klaus Menges, Paul Messinger, Hans-Jürgen Mest, Frank Peter Meyer, J. Mollière, Rudolf Morgenstern, Wolfgang Morick, Joachim Mössner, Christa Müller, Daniel Müller, Klaus Müller, Walter Müller, Alexander Mülsch, Tilo Netzer, Michael Neugebauer, Ulf Niemeyer, Peter Nuhn, Bernd Nürnberg, Joachim Oertel, Michael Oettel, Hartmut Oßwald, Robert Ott, Tilmann Ott, Thomas Otzen, Peter Pachaly, Helmut Pelzer, Karl-Uwe Petersen, Martina Pickert, Andreas Pies, Klaus Pietrzik, Detlef Preiss, Helmut Priewer, Olaf Queckenberg, Eberhard Reimann, Jörg Remien, Rainer Rettig, Andreas Reymann, Joachim Richter, Hans Rommelspacher, Ulrich Rose, Gerhard Rücker, Klaus Schaefer, Helmut Schlager, Werner Schleicher, Hildegard Schleinitz, Wolfgang Schlichter, Helmut Schmidhammer, Gerhard Schmidt, Timo Schmidt, Johannes Schräder, Thomas Schulz, Gert Schulze, Peter Schwanz, Helmut Schwilden, Monika Serke, Gisela Skopp, Marcus Spohn, Ralf Stahlmann, Johannes-Peter Stasch, Christian Steffen, Jürgen Steinmeyer, Karl-Heinz Surborg, Ulf Sürig, Istvan Szelenyi, Reinhard Troschütz, Michael Verborg, Eugen J. Verspohl, Franz-Josef Volk, Heinz Walther, Horst Weber, Judith Wede, Martin Wenzel, Marion Weyandt-Spangenberg, Sandra Wich, Hilke Winterhoff, Reinhold Wintersteiger, Frauke Woltmann, Diaa Youssef & A. Ziegler. 1994. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis
485
543
.
M. Breda, E. Pianezzola, M. Strolin Benedetti, C. Efthymiopoulos, M. Carpentieri, D. Sassella & R. Rimoldi. (1992) A STUDY OF THE EFFECTS OF RIFABUTIN ON ISONIAZID PHARMACOKINETICS AND METABOLISM IN HEALTHY VOLUNTEERS. Drug Metabolism and Drug Interactions 10:4.
Crossref